Enhancing TB Therapy with Precision: Immunomodulatory Nanoparticles Co-Delivering Rifampicin and Vitamin D3 for Macrophage-Targeted Treatment
- DOI
- 10.1021/acs.molpharmaceut.6c00601
- Published
- 2026-10-14
- Container
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acs.molpharmaceut.6c00601,
title = {Enhancing TB Therapy with Precision: Immunomodulatory Nanoparticles Co-Delivering Rifampicin and Vitamin D3 for Macrophage-Targeted Treatment},
author = {Leon J. Khoza and Pradeep Kumar and Admire Dube and Bhavna G. Gordhan and Bavesh D. Kana and Yahya E. Choonara},
year = {2026},
journal = {Molecular Pharmaceutics},
doi = {10.1021/acs.molpharmaceut.6c00601},
url = {https://doi.org/10.1021/acs.molpharmaceut.6c00601}
}RIS
TY - JOUR TI - Enhancing TB Therapy with Precision: Immunomodulatory Nanoparticles Co-Delivering Rifampicin and Vitamin D3 for Macrophage-Targeted Treatment AU - Leon J. Khoza AU - Pradeep Kumar AU - Admire Dube AU - Bhavna G. Gordhan AU - Bavesh D. Kana AU - Yahya E. Choonara PY - 2026 JO - Molecular Pharmaceutics DO - 10.1021/acs.molpharmaceut.6c00601 UR - https://doi.org/10.1021/acs.molpharmaceut.6c00601 ER -
APA
Khoza, L. J., Kumar, P., Dube, A., Gordhan, B. G., Kana, B. D., & Choonara, Y. E. (2026). Enhancing TB Therapy with Precision: Immunomodulatory Nanoparticles Co-Delivering Rifampicin and Vitamin D3 for Macrophage-Targeted Treatment. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00601
Source records
- crossref · retrieved 2026-11-03T19:40:36.791Z